Showing results (341-350 of 520) with videos related to
Sort By:
Pageof 52
Targeted Oncology|September 22, 2019
Therapeutic Targeting of Golgi Phosphoprotein 2 (GOLPH2) with Armed Antibodies: A Preclinical Study of Anti-GOLPH2 Antibody Drug Conjugates in Lung and Colorectal Cancer Models of Patient Derived Xenografts (PDX)Heike Liewen, Norbert Markuly, Heinz Läubli, et al.Carbohydrate Polymers|June 18, 2016
Synthesis, characterization, and self-assembly with plasmid DNA of a quaternary ammonium derivative of pectic galactan and its fluorescent labeling for bioimaging applicationsRamesh Chintakunta, Nitsa Buaron, Nicole Kahn, et al.Brachytherapy|May 12, 2009
Photon activation therapy and brachytherapyBrenda H Laster, Dabney W Dixon, Sara Novick, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 16, 2010
Tumor-specific crosslinking of GITR as costimulation for immunotherapyTanja Burckhart, Markus Thiel, Hiroyoshi Nishikawa, et al.Scientific Reports|January 14, 2018
Targeting Insulin-Like Growth Factor-I and Extracellular Matrix Interactions in Melanoma ProgressionBerline Murekatete, Ali Shokoohmand, Jacqui McGovern, et al.Journal of Orthopaedics|June 19, 2025
Longitudinal analysis of radiological parameters after monosegmental lumbar instrumentation and posterior lumbar interbody fusion (PLIF) compared with transforaminal lumbar interbody fusion (TLIF)Hassan Awan Malik, Andreas Kiebler, Julia Müller, et al.International Journal of Pediatric Otorhinolaryngology|January 27, 2012
Circulating cytokines in patients undergoing tonsillectomy with fibrin glueL Stiller-Timor, A D Goldbart, N Segal, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|May 6, 2014
Quaternized starch-based carrier for siRNA delivery: from cellular uptake to gene silencingEliz Amar-Lewis, Aharon Azagury, Ramesh Chintakunta, et al.Pediatric Pulmonology|November 28, 2017
Nitric oxide inhalations in bronchiolitis: A pilot, randomized, double-blinded, controlled trialAsher Tal, David Greenberg, Yossef Av-Gay, et al.Cancer Immunology, Immunotherapy : CII|June 8, 2014
The microtubule-depolymerizing agent ansamitocin P3 programs dendritic cells toward enhanced anti-tumor immunityKea Martin, Philipp Müller, Jens Schreiner, et al.Pageof 52